Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients

The expression of mesothelin correlates with a poor prognosis in patients with breast cancer. Since mesothelin plays a role in cancer metastasis in association with CA125, we herein examined the expression of mesothelin and CA125, and the clinicopathological meaning and prognosis of the co-expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Einama, Takahiro, Yamagishi, Yoji, Takihata, Yasuhiro, Suzuki, Takafumi, Yamasaki, Tamio, Hirose, Yuichi, Kobayashi, Kazuki, Yonamine, Naoto, Fujinuma, Ibuki, Tsunenari, Takazumi, Koga, Makiko, Ishibashi, Yusuke, Nagata, Ken, Shiraishi, Takehiro, Nakazawa, Akiko, Iwasaki, Toshimitsu, Shinto, Eiji, Kato, Kimi, Sato, Kimiya, Ueno, Hideki, Kishi, Yoji, Tsuda, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555316/
https://www.ncbi.nlm.nih.gov/pubmed/34715925
http://dx.doi.org/10.1186/s40364-021-00335-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555316/
https://www.ncbi.nlm.nih.gov/pubmed/34715925
http://dx.doi.org/10.1186/s40364-021-00335-3

Ejemplares similares